View this on-demand webinar for an in-depth discussion on patient outcomes tracking through registries and how leveraging outcomes data collected from the first-generation of approved cell and gene therapies can inform the advancement of future cell and gene therapy products. Also included is a Q&A session between live webinar attendees and the following experts:
- Marcelo C. Pasquini, MD, senior scientific director, CIBMTR® (Center for International Blood and Marrow Transplant Research®)
- Dawn Henke, PhD, senior technical program manager, Standards Coordinating Body
- Charles Wilfong, global vice president, Information Management & Facility Engineering Functions, Adaptimmune